BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 10434774)

  • 1. [Therapy of amiodarone-induced thyrotoxicosis and hypothyroidism].
    Gerber H; Noth D
    Ther Umsch; 1999 Jul; 56(7):374-9. PubMed ID: 10434774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Amiodarone and the thyroid gland].
    Bednarek-Tupikowska G; Filus A; Kuliczkowska J; Bugajski J
    Postepy Hig Med Dosw (Online); 2004 Apr; 58():216-25. PubMed ID: 15114257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amiodarone and thyroid dysfunction.
    Padmanabhan H
    South Med J; 2010 Sep; 103(9):922-30. PubMed ID: 20689491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of amiodarone on the thyroid.
    Martino E; Bartalena L; Bogazzi F; Braverman LE
    Endocr Rev; 2001 Apr; 22(2):240-54. PubMed ID: 11294826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amiodarone and the thyroid.
    Jabrocka-Hybel A; Bednarczuk T; Bartalena L; Pach D; Ruchała M; Kamiński G; Kostecka-Matyja M; Hubalewska-Dydejczyk A
    Endokrynol Pol; 2015; 66(2):176-86. PubMed ID: 25931048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amiodarone-induced thyrotoxicosis. A review.
    Piga M; Serra A; Boi F; Tanda ML; Martino E; Mariotti S
    Minerva Endocrinol; 2008 Sep; 33(3):213-28. PubMed ID: 18846027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of amiodarone-induced thyrotoxicosis in Latin America: an electronic survey.
    Diehl LA; Romaldini JH; Graf H; Bartalena L; Martino E; Albino CC; Wiersinga WM
    Clin Endocrinol (Oxf); 2006 Oct; 65(4):433-8. PubMed ID: 16984234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Approach to the patient with amiodarone-induced thyrotoxicosis.
    Bogazzi F; Bartalena L; Martino E
    J Clin Endocrinol Metab; 2010 Jun; 95(6):2529-35. PubMed ID: 20525904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical characteristics of amiodarone-induced thyrotoxicosis and hypothyroidism in Japan.
    Sato K; Miyakawa M; Eto M; Inaba T; Matsuda N; Shiga T; Ohnishi S; Kasanuki H
    Endocr J; 1999 Jun; 46(3):443-51. PubMed ID: 10503998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amiodarone-induced thyroid dysfunction.
    Danzi S; Klein I
    J Intensive Care Med; 2015 May; 30(4):179-85. PubMed ID: 24067547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Amiodarone-induced thyrotoxicosis].
    Bogazzi F; Tomisti L; Di Bello V; Martino E
    G Ital Cardiol (Rome); 2017 Mar; 18(3):219-229. PubMed ID: 28398380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The various effects of amiodarone on thyroid function.
    Bogazzi F; Bartalena L; Gasperi M; Braverman LE; Martino E
    Thyroid; 2001 May; 11(5):511-9. PubMed ID: 11396710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Role of Radiopharmaceuticals in Amiodarone-Induced Thyroid Pathology.
    Irimie A; Piciu D
    Curr Radiopharm; 2017 Nov; 10(3):146-154. PubMed ID: 28814251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amiodarone and the thyroid: a 2012 update.
    Bogazzi F; Tomisti L; Bartalena L; Aghini-Lombardi F; Martino E
    J Endocrinol Invest; 2012 Mar; 35(3):340-8. PubMed ID: 22433945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of amiodarone-associated thyrotoxicosis.
    Franklyn JA; Gammage MD
    Nat Clin Pract Endocrinol Metab; 2007 Sep; 3(9):662-6. PubMed ID: 17710087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radioiodine therapy in patients with amiodarone-induced thyrotoxicosis (AIT).
    Czarnywojtek A; Czepczynski R; Ruchala M; Wasko R; Zgorzalewicz-Stachowiak M; Szczepanek E; Zamyslowska H; Bartkowiak Z; Florek E; Sowinski J
    Neuro Endocrinol Lett; 2009; 30(2):209-14. PubMed ID: 19675515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis and management of amiodarone-induced thyrotoxicosis in Europe: results of an international survey among members of the European Thyroid Association.
    Bartalena L; Wiersinga WM; Tanda ML; Bogazzi F; Piantanida E; Lai A; Martino E
    Clin Endocrinol (Oxf); 2004 Oct; 61(4):494-502. PubMed ID: 15473883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Iopanoic acid rapidly controls type I amiodarone-induced thyrotoxicosis prior to thyroidectomy.
    Bogazzi F; Aghini-Lombardi F; Cosci C; Lupi I; Santini F; Tanda ML; Miccoli P; Basolo F; Pinchera A; Bartalena L; Braverman LE; Martino E
    J Endocrinol Invest; 2002 Feb; 25(2):176-80. PubMed ID: 11929091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis and management of amiodarone-induced thyrotoxicosis: similarities and differences between North American and European thyroidologists.
    Tanda ML; Piantanida E; Lai A; Liparulo L; Sassi L; Bogazzi F; Wiersinga WM; Braverman LE; Martino E; Bartalena L
    Clin Endocrinol (Oxf); 2008 Nov; 69(5):812-8. PubMed ID: 18410546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clinical value of regular thyroid function tests during amiodarone treatment.
    Benjamens S; Dullaart RPF; Sluiter WJ; Rienstra M; van Gelder IC; Links TP
    Eur J Endocrinol; 2017 Jul; 177(1):9-14. PubMed ID: 28424174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.